ABCB5 | ATP-binding cassette, sub-family B (MDR/TAP), member 5 | Predicted membrane proteins Transporters
| ![](/images/26975/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26975/60053_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif, 14 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| ![](/images/34605/ihc_selected_60x60.jpg) | ![](/images/34605/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/34605/68654_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS16 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 | Enzymes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ANXA13 | Annexin A13 | Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/19650/151980_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
B3GALT2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 | Predicted membrane proteins
| ![](/images/55372/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/55372/126762_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
BDKRB1 | Bradykinin receptor B1 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/2935/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2935/8078_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
C4orf6 | Chromosome 4 open reading frame 6 | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
C6orf141 | Chromosome 6 open reading frame 141 | | ![](/images/36199/ihc_selected_60x60.jpg) | ![](/images/36199/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/36199/106018_B_9_6_rna_selected_60x60.jpg) | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/17107/39741_A_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
CAPN12 | Calpain 12 | Enzymes
| ![](/images/43492/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43492/96402_B_1_4_rna_selected_60x60.jpg) | Tissue enhanced |
CATSPERB | Catsper channel auxiliary subunit beta | Predicted membrane proteins Transporters
| ![](/images/35134/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35134/72427_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CCL20 | Chemokine (C-C motif) ligand 20 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CHRM2 | Cholinergic receptor, muscarinic 2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/29795/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29795/62922_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CILP2 | Cartilage intermediate layer protein 2 | Predicted secreted proteins
| ![](/images/41847/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41847/89727_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CLDN2 | Claudin 2 | Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/2609/6566_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
COL10A1 | Collagen, type X, alpha 1 | Disease related genes Predicted secreted proteins
| ![](/images/53268/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/53268/122318_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
COL3A1 | Collagen, type III, alpha 1 | Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images/16766/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16766/38380_B_1_4_rna_selected_60x60.jpg) | Tissue enhanced |
COLEC11 | Collectin sub-family member 11 | Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images/35241/ihc_selected_60x60.jpg) | ![](/images/35241/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/35241/72127_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
COMP | Cartilage oligomeric matrix protein | Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CPA3 | Carboxypeptidase A3 (mast cell) | Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20712/51061_A_3_5_rna_selected_60x60.jpg) | Tissue enhanced |
CPXM1 | Carboxypeptidase X (M14 family), member 1 | Enzymes Predicted secreted proteins
| ![](/images/55044/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/55044/129810_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CRLF2 | Cytokine receptor-like factor 2 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CTHRC1 | Collagen triple helix repeat containing 1 | Disease related genes Predicted secreted proteins
| | ![](/images/61896/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/59806/140822_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CXCL6 | Chemokine (C-X-C motif) ligand 6 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
DCDC1 | Doublecortin domain containing 1 | Cancer-related genes
| ![](/images/40042/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40042/97444_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
DEPDC1B | DEP domain containing 1B | | ![](/images/38255/ihc_selected_60x60.jpg) | ![](/images/38255/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38255/82099_B_4_5_rna_selected_60x60.jpg) | Tissue enhanced |
DUOX2 | Dual oxidase 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
DUOXA2 | Dual oxidase maturation factor 2 | Disease related genes Predicted membrane proteins
| ![](/images/11085/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11085/28066_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
F2RL2 | Coagulation factor II (thrombin) receptor-like 2 | G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
FAM150A | Family with sequence similarity 150, member A | Predicted secreted proteins
| ![](/images/27368/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/27368/58662_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
FAM180A | Family with sequence similarity 180, member A | Predicted secreted proteins
| ![](/images/21224/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21224/47564_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
FGF5 | Fibroblast growth factor 5 | Predicted secreted proteins RAS pathway related proteins
| ![](/images/10313/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/10313/30429_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
FGF7 | Fibroblast growth factor 7 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| ![](/images/43605/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43605/96644_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
FNDC1 | Fibronectin type III domain containing 1 | Predicted secreted proteins
| ![](/images/30962/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/30962/72778_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
FOSL1 | FOS-like antigen 1 | Cancer-related genes Plasma proteins Transcription factors
| ![](/images/4396/ihc_selected_60x60.jpg) | | | ![](/images/4396/19547_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
FOXL1 | Forkhead box L1 | Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
GEM | GTP binding protein overexpressed in skeletal muscle | | ![](/images/24798/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24798/58731_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
GLP2R | Glucagon-like peptide 2 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49244/122475_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
GPBAR1 | G protein-coupled bile acid receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62890/141592_B_5_1_rna_selected_60x60.jpg) | Tissue enhanced |
GPX2 | Glutathione peroxidase 2 (gastrointestinal) | Cancer-related genes Enzymes
| ![](/images/3545/ihc_selected_60x60.jpg) | ![](/images/3545/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/3545/11283_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
GREM1 | Gremlin 1, DAN family BMP antagonist | Disease related genes Predicted secreted proteins
| ![](/images/7526/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7526/23507_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
GREM2 | Gremlin 2, DAN family BMP antagonist | Predicted secreted proteins
| ![](/images/9920/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/9920/ihc_cell_selected_60x60.jpg) | ![](/images/9920/32511_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
HMSD | Histocompatibility (minor) serpin domain containing | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ITGBL1 | Integrin, beta-like 1 (with EGF-like repeat domains) | Predicted secreted proteins
| ![](/images/5676/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5676/20058_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
KCNS1 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 | Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
KERA | Keratocan | Disease related genes Predicted secreted proteins
| ![](/images/39321/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39321/85980_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
KRT222 | Keratin 222 | | ![](/images/43708/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43708/97713_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
LCN2 | Lipocalin 2 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2695/8562_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
LGALS2 | Lectin, galactoside-binding, soluble, 2 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3536/10540_A_7_1_rna_selected_60x60.jpg) | Tissue enhanced |
LHX8 | LIM homeobox 8 | Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |